Joe, sorry you are having to deal with this mess which you

New Post Public Reply Private Reply Replies (1) Message Board
tc2000chartreader MMPJOE #9346
242
Joe, sorry you are having to deal with this mess which you have worked SO HARD for us shareholders!

What are your thoughts on going to CMF and telling them they must buy 2M restricted shares from Generex (share count goes up 2M) at the price of $2.50/share that has been used in all your deals. This would give $5M to Generex. Then Generex would announce a share repurchase agreement on the open market for $5M to be completed in 1 month. This puts CMF back in compliance, and allows Generex to control the repurchase in the open market, so the share price can rise on Generex's terms and not be done on CMF advantage of buying shares at a low price here.

Thoughts?
Quote:
Also what was said doing the dividend would put another 21 million that we’d have to chew threw if the dividend was paid to everyone, plus the 23 mill approx was supposed to be, for close to 90 million shares, at 40 cents - plus 40 million at 40 cents in the financing hahaha good luck getting over 40 cents for a very long time as I said in the call, that’s why we have to find out what’s the legalities, are the waivers still in effect, what legal remedies do we have, just doing a dividend cutting us in half and then never getting over 40 cents again for a very long time would mean no nasdaq listing, so what your saying is your fine staying on the otc, your fine chewing threw an additional 20 million shares plus plus plus, humm ok duly noted. Like I said here and on the call we will have answers this week.

Read More: https://investorshangout.com/post/newpost/622...z670YvyYHK

Generex Biotechnology Corp. (GNBTQ) Stock Research Links

GNBTQ Board Company Profile Buy Rating Time & Sales News Filings Financials
Disclaimer: Of course, all of this is my opinion and you should not make any investment decisions based on my opinion. I have not received any non-public information.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

HONA Faces Legal Heat: Investor Lawsuit Over Losses

Updated Category News Views 5

The Investor Storm Brewing Over Honeywell Aerospace There it is again, another industry heavyweight caught in a dizzying whirlwind of litigation. Honeywell Aerospace Inc. (NASDAQ:HONA), a name as established as an old boot in the business, now faces a class action lawsuit that's got investors frantically dusting off phone numbers for their attorneys. The Messy Allegations...

Continue Reading
CVS Health Under Fire: Fiduciary Duty Breach?

Updated Category News Views 2

CVS Under Regulatory Spotlight for Fiduciary Breaches You'd think by now companies would have their fiduciary ducks in a row. But here we are, with CVS Health Corporation (NYSE: CVS) catching heat from the legal eagles over at Halper Sadeh LLC. The knife’s out for some of the big wigs – apparently, there's chatter they might’ve slipped on their duty to play nice...

Continue Reading
AI and Storytelling Make Waves in Science Education

Updated Category News Views 4

University's Innovative Approach to Learning Alright, here's something you don't see every day. The University of Phoenix managed to snag some kudos from an academic journal for using AI and storytelling to teach environmental science. That's like hitting two bulls-eyes with one shot in the world of education. The recognition from Glacies for this Editor's Choice paper...

Continue Reading
Krispy Kreme Faces Legal Probe: Fiduciary Breach?

Updated Category News Views 3

Diving Deep into the Krispy Kreme Allegations Look, this isn't your run-of-the-mill donut drama. When you hear rumblings of corporate missteps, especially ones that involve potential breaches of fiduciary duties, it's time to perk up those ears. Over at Krispy Kreme, Inc. (NASDAQ:DNUT), there's some heat in the kitchen, and it's not just from frying those glazed beauties....

Continue Reading
Geron Corp Faces Fiduciary Duty Investigation

Updated Category News Views 4

Spotlight on Geron's Corporate Governance: What's Happening? The heat's been turned up on Geron Corporation this week, with Halper Sadeh LLC, an investor rights law outfit, digging into whether some folks at the helm have strayed from their fiduciary duties to the shareholders. Now, if you're holding onto NASDAQ:GERN stock or thinking about diving in, it's high time to...

Continue Reading
Jackson Wang's Fantasy IP Hits Hong Kong Stage

Updated Category News Views 4

A Star-Studded Fantasy Comes Alive Hong Kong isn't just about dim sum and skyline views—it's a magnet for celebrity showcases, and this time, Jackson Wang's pulling the strings. The guy's ventured beyond music and idol fame, diving head-first into creative visuals with his fantasy IP, "Under the Castle" (UTC). Pairing up with Ocean Park's Halloween Fest, he's cooked up...

Continue Reading
PACS Group Faces Legal Scrutiny: What to Watch

Updated Category News Views 3

PACS Group: Legal Storm Brewing Welcome to the latest saga in the volatile theater of corporate governance. PACS Group, Inc., ticker symbol NYSE:PACS, is under the microscope, and not for debuting a groundbreaking product or hitting a stock milestone. Nope, instead we've got Halper Sadeh LLC out of New York investigating some possible hanky-panky from PACS directors and...

Continue Reading
Quay Sunglasses: Luxury Looks, Affordable Prices

Updated Category News Views 3

Ah, sunglasses—the quintessential accessory that screams both practicality and style. A million-dollar look without the million-dollar expense? That's where Quay comes in. They've been recognized by Expert Consumers, no less, as some of the best-in-class for affordable luxury eye candy out there—aimed at shoppers who want the designer vibe without the hemorrhaging...

Continue Reading

Top 5 Most Recently Viewed Articles

UJET Secures $76 Million Funding Boost to Enhance AI Solutions

Updated Category News Views 49

UJET Secures Major Funding to Advance AI Innovations UJET, Inc., a leading name in AI-powered cloud contact center solutions, has proudly announced the successful completion of its latest funding round. This impressive Series D funding raised a total of $76 million, spearheaded by Sapphire Ventures, with significant contributions from investors like KeyCorp and...

Continue Reading
Vantage Strengthens Cloud Cost Management with FinOps Membership

Updated Category News Views 165

Vantage Becomes a Premier Member of the FinOps Foundation Vantage, well-known for its leadership in cloud cost management, is thrilled to announce that it has joined the FinOps Foundation. This step marks a pivotal moment for the company as it commits to enhancing cloud financial operations. Vantage provides actionable insights that empower engineers with the necessary...

Continue Reading
EDAP TMS Reports Successful FARP Trial Outcomes for Prostate Cancer

Updated Category News Views 180

Positive Results from the FARP Trial Announced EDAP TMS SA (Nasdaq: EDAP), a frontrunner in robotic energy-based therapies, has recently announced encouraging results from its Focal Ablation Versus Radical Prostatectomy (FARP) randomized controlled trial (RCT). This groundbreaking study was designed to compare the efficacy of ultrasound energy-based focal ablation with...

Continue Reading
Lawsuit Filed Over Alleged Risks Linked to Neptune's Fix Elixir

Updated Category News Views 126

Examining the Legal Case Against Neptune Resources A significant legal case has captured the public's attention. The law firm Feldman Shepherd Wohlgelernter Tanner Weinstock Dodig LLP is taking action on behalf of the family of a young man named Matthew Cornier, who tragically passed away after using Neptune's Fix Elixir. The 32-year-old Cornier, a skilled Graphic Design...

Continue Reading
Exploring Nature’s Sunshine's Upcoming Financial Insights Call

Updated Category News Views 162

Nature’s Sunshine Announces Conference Call for Financial Results Nature’s Sunshine Products, Inc. (Nasdaq: NATR) is gearing up to share exciting insights into its financial performance with a conference call set for a specified future date. This call is an excellent opportunity for stakeholders and interested parties to learn more about the company’s latest...

Continue Reading